SynthesisJAMA oncology2017

FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis.

Gianluca Tomasello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.